Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges - Test2 - elhamkhani - TriplyDB

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

http://www.wikidata.org/entity/Q26745928

about

Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides.Pyroglutamate-modified Aβ(3-42) affects aggregation kinetics of Aβ(1-42) by accelerating primary and secondary pathways.Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.Computational Analysis for the Rational Design of Anti-Amyloid Beta (Aβ) Antibodies

P2860

Q37397677-C3100C4E-46EE-4158-837B-DB99D5BAA21E Q37604055-5ED94184-A0FC-407F-896B-99C41DC5286B Q42363417-75DE5A1A-B858-48A2-836D-308FF2E65FEE Q46257047-7A150B49-58C0-43EB-96C7-3E1627262228 Q50532471-06EC24B4-81C4-46AE-A0BF-42B3D897A2D3 Q54982684-A5CC00AA-11A3-411C-BDDC-3E027FF4ACC7 Q57903229-2D8820A0-960E-4DE6-8B96-83C56EDE0E21

P2860

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

http://www.wikidata.org/entity/Q26745928

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@ast

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@en

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@nl

type

label

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@ast

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@en

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@nl

prefLabel

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@ast

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@en

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@nl

P1433

Q26745928-157926FB-0464-4C6F-97EF-9CB58D80E514

P1476

Q26745928-4A3EAF07-22FD-466E-A633-5B58FF7D1DCC

P2093

Q26745928-0558F071-327F-4561-8618-CFD08D0D4527

Q26745928-DE79EDB6-D564-4DB6-B950-5AA272CB7710

P275

Q26745928-00303F22-E20D-4E96-9B6F-BAE6BD4EE4BB

P2860

Q26745928-0042A9FA-152B-4A56-8C57-94868A902611

Q26745928-01BCB663-C0E2-46FE-AF08-2C889DEFDAD3

Q26745928-076E35A9-E145-4FB6-8A80-782DB7B9CF47

Q26745928-07E0677A-D8F9-44D6-BDC2-0C0E27ABF305

Q26745928-08A1A538-A7BA-4885-B543-E2553FA7DB0B

Q26745928-0A3B2D4A-C345-4EE6-A3AD-3126E1161EAD

Q26745928-0E6C82D8-2D45-4798-9961-EDE76A4B38A3

Q26745928-184584A4-56DC-4BBC-8F1F-8C2F437CE05C

Q26745928-187878E0-488F-4E6B-BD61-427732D2F17F

Q26745928-20B1266B-CE7D-4EDC-8273-7D73D7B2EE50

P2888

Q26745928-AE636E08-467F-4400-B9E3-0C76B70A2C5D

P304

Q26745928-E87C543E-F304-4BEC-AC18-80CD9E874CAB

P31

Q26745928-14691C61-BA8F-47FD-AA5D-54815F9B4EA8

Q26745928-6172D1BD-57E1-4DB0-BC22-9AB549A4EB24

P3181

Q26745928-5157B048-6639-42B3-83F1-FA48D5AB1D90

P356

Q26745928-D4A5B2E7-3538-4B29-B338-AF2E17B3828C

P407

Q26745928-56B6BFFD-9AC3-4E6C-99E7-4E8610B0CCFE

P433

Q26745928-81F983E4-BA6F-4C15-A96C-39162CD939CF

P478

Q26745928-1D1C82A4-5599-4C84-B863-6D8E031B4D68

P50

Q26745928-AACE1CFE-FB75-4518-B074-DA1434D4EC81

Q26745928-AC54F4F8-1F4C-42F1-969E-B9242AD83436

P5008

Q26745928-6B5F5F7E-2C31-41A4-BB4A-BC1D73ED7AE7

P577

Q26745928-3E413584-F905-4096-B94B-2CDF8AB03C39

P6179

Q26745928-318AE43A-47C1-4CDA-ADAF-89127E71A458

P698

Q26745928-876E0EC9-4723-46C6-9AFD-D9C3A1E5DD5A

P921

Q26745928-752C6488-098A-4FFA-BE7F-85695F8BC1C7

Q26745928-B061485D-9674-4F75-B7BA-40414B59A5EE

Q26745928-B28CAFED-41DB-4021-A173-3C7659BAA9B7

Q26745928-B39A6DDB-EABF-4B9E-BEEF-58C5EFE818AF

Q26745928-BB30FBE6-68D7-450D-9615-62F39CB03F6D

Q26745928-D388CC43-CE9C-4E28-8877-19457E951D66

P932

Q26745928-21C9AE91-C219-4FD8-96D4-8B82FEB2AD98

P3181

P356

S13024-016-0115-2

P1433

Molecular Neurodegeneration

P1476

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

@en

P2093

Helen Crehan

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Frost

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Global prevalence of dementia: a Delphi consensus study

Molecular basis for passive immunotherapy of Alzheimer's disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Alzheimer's disease: genes, proteins, and therapy

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

The gamma-secretase complex: membrane-embedded proteolytic ensemble

P2888

s13024-016-0115-2

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

347801

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S13024-016-0115-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Cynthia A Lemere

P5008

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021616118

http://www.w3.org/2001/XMLSchema#string

P698

27363697

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

heterocyclic compound

protein precursor

membrane proteins

P932

4929720

http://www.w3.org/2001/XMLSchema#string